AMERICAN SHARED HOSPITAL SER (AMS) Fundamental Analysis & Valuation

NYSEARCA:AMS • US0295951059

Current stock price

2.03 USD
+0.01 (+0.5%)
Last:

This AMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AMS Profitability Analysis

1.1 Basic Checks

  • In the past year AMS has reported negative net income.
  • In the past year AMS had a positive cash flow from operations.
  • AMS had positive earnings in 4 of the past 5 years.
  • In the past 5 years AMS always reported a positive cash flow from operatings.
AMS Yearly Net Income VS EBIT VS OCF VS FCFAMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

  • AMS has a worse Return On Assets (-3.84%) than 63.37% of its industry peers.
  • With a Return On Equity value of -9.97%, AMS perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
Industry RankSector Rank
ROA -3.84%
ROE -9.97%
ROIC N/A
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
AMS Yearly ROA, ROE, ROICAMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • In the last couple of years the Profit Margin of AMS has grown nicely.
  • In the last couple of years the Operating Margin of AMS has declined.
  • Looking at the Gross Margin, with a value of 24.43%, AMS is in line with its industry, outperforming 51.49% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AMS has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for AMS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.43%
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
AMS Yearly Profit, Operating, Gross MarginsAMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AMS Health Analysis

2.1 Basic Checks

  • AMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AMS has been increased compared to 1 year ago.
  • The number of shares outstanding for AMS has been increased compared to 5 years ago.
  • The debt/assets ratio for AMS is higher compared to a year ago.
AMS Yearly Shares OutstandingAMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
AMS Yearly Total Debt VS Total AssetsAMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • AMS has an Altman-Z score of 0.84. This is a bad value and indicates that AMS is not financially healthy and even has some risk of bankruptcy.
  • AMS has a worse Altman-Z score (0.84) than 70.30% of its industry peers.
  • AMS has a Debt/Equity ratio of 0.58. This is a neutral value indicating AMS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.58, AMS perfoms like the industry average, outperforming 59.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACCN/A
WACC9%
AMS Yearly LT Debt VS Equity VS FCFAMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • AMS has a Current Ratio of 1.17. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.
  • AMS has a Current ratio (1.17) which is in line with its industry peers.
  • AMS has a Quick Ratio of 1.17. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.
  • AMS's Quick ratio of 1.17 is in line compared to the rest of the industry. AMS outperforms 49.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
AMS Yearly Current Assets VS Current LiabilitesAMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. AMS Growth Analysis

3.1 Past

  • AMS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -950.00%.
  • Measured over the past years, AMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.28% on average per year.
  • AMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.90%.
  • The Revenue has been growing slightly by 6.58% on average over the past years.
EPS 1Y (TTM)-950%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%100%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%2.46%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y44.91%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.01%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMS Yearly Revenue VS EstimatesAMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AMS Yearly EPS VS EstimatesAMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. AMS Valuation Analysis

4.1 Price/Earnings Ratio

  • AMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMS Price Earnings VS Forward Price EarningsAMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • AMS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMS is cheaper than 96.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.42
AMS Per share dataAMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMS Dividend Analysis

5.1 Amount

  • AMS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMS Fundamentals: All Metrics, Ratios and Statistics

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (3/19/2026, 8:04:00 PM)

2.03

+0.01 (+0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13
Earnings (Next)04-02
Inst Owners13.46%
Inst Owner Change7.74%
Ins Owners35.91%
Ins Owner Change0%
Market Cap13.34M
Revenue(TTM)28.34M
Net Income(TTM)-2.44M
Analysts80
Price Target4.59 (126.11%)
Short Float %0.11%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.21%
Min EPS beat(2)0.99%
Max EPS beat(2)43.42%
EPS beat(4)2
Avg EPS beat(4)-543.23%
Min EPS beat(4)-2080.2%
Max EPS beat(4)43.42%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-3.97%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)0.93%
Min Revenue beat(4)-7.97%
Max Revenue beat(4)16.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 4.64
P/B 0.54
P/tB 0.58
EV/EBITDA 3.42
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)0.44
OCFY21.57%
SpS4.45
BVpS3.73
TBVpS3.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE -9.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.43%
FCFM N/A
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.05%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 2.28
Cap/Depr 182.58%
Cap/Sales 39.16%
Interest Coverage N/A
Cash Conversion 46.15%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 0.84
F-Score4
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)86.06%
Cap/Depr(5y)59.68%
Cap/Sales(3y)19.8%
Cap/Sales(5y)14.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-950%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%100%
EPS Next Y44.91%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.9%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%2.46%
Revenue Next Year8.01%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.77%
EBIT growth 3Y-6.85%
EBIT growth 5Y-9.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-255.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.59%
OCF growth 3Y-70.14%
OCF growth 5Y-53.93%

AMERICAN SHARED HOSPITAL SER / AMS Fundamental Analysis FAQ

What is the fundamental rating for AMS stock?

ChartMill assigns a fundamental rating of 2 / 10 to AMS.


What is the valuation status of AMERICAN SHARED HOSPITAL SER (AMS) stock?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN SHARED HOSPITAL SER (AMS). This can be considered as Overvalued.


How profitable is AMERICAN SHARED HOSPITAL SER (AMS) stock?

AMERICAN SHARED HOSPITAL SER (AMS) has a profitability rating of 3 / 10.


What is the earnings growth outlook for AMERICAN SHARED HOSPITAL SER?

The Earnings per Share (EPS) of AMERICAN SHARED HOSPITAL SER (AMS) is expected to grow by 44.91% in the next year.